Vascular Leptomeningeal Cells

Vascular Leptomeningeal Cells

Introduction

Vascular Leptomeningeal Cells is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-cell"> [@iliff2012]
<table> [@van2009]
<tr><th colspan="2" style="background:#f0f0f0;">Vascular Leptomeningeal Cells</th></tr> [@louveau2015]
<tr><td><b>Category</b></td><td>Meningeal Cells</td></tr> [@kyrtsos2015]
<tr><td><b>Location</b></td><td>Leptomeninges (pia and arachnoid mater)</td></tr> [@michalski2021]
<tr><td><b>Cell Type</b></td><td>Fibroblast-like stromal cells</td></tr>
<tr><td><b>Function</b></td><td>Extracellular matrix production, BBB maintenance</td></tr>
</table>
</div>

Overview

Vascular Leptomeningeal Cells

Introduction

Vascular Leptomeningeal Cells is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-cell"> [@iliff2012]
<table> [@van2009]
<tr><th colspan="2" style="background:#f0f0f0;">Vascular Leptomeningeal Cells</th></tr> [@louveau2015]
<tr><td><b>Category</b></td><td>Meningeal Cells</td></tr> [@kyrtsos2015]
<tr><td><b>Location</b></td><td>Leptomeninges (pia and arachnoid mater)</td></tr> [@michalski2021]
<tr><td><b>Cell Type</b></td><td>Fibroblast-like stromal cells</td></tr>
<tr><td><b>Function</b></td><td>Extracellular matrix production, BBB maintenance</td></tr>
</table>
</div>

Overview

Vascular Leptomeningeal Cells (VLMCs) are specialized fibroblast-like cells that constitute a critical component of the leptomeninges—the combined pia mater and arachnoid mater that envelop the brain and spinal cord. These cells are the principal producers of the meningeal extracellular matrix, including collagen fibers, elastin, and proteoglycans that provide structural support and mechanical protection to the central nervous system. VLMCs line cerebral blood vessels, forming the perivascular space and playing essential roles in blood-brain barrier (BBB) maintenance, cerebrospinal fluid (CSF) circulation, and immune cell trafficking. Recent research has revealed that VLMCs undergo substantial changes in neurodegenerative diseases, contributing to amyloid angiopathy, neuroinflammation, and impaired CSF drainage [1][2].

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:4023051](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023051) | vascular leptomeningeal cell |

External Database Links

• [Cell Ontology (CL:4023051)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023051)
• [OBO Foundry (CL:4023051)](http://purl.obolibrary.org/obo/CL_4023051)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Taxonomy & Classification

| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:4023051](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023051) | vascular leptomeningeal cell | Exact |
| Cell Ontology | [CL:4023056](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023056) | vascular leptomeningeal cell (Mmus) | Exact |

External Database Links

• [Cell Ontology (CL:4023051)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023051)
• [OBO Foundry (CL:4023051)](http://purl.obolibrary.org/obo/CL_4023051)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)

Neuroanatomy

Distribution

VLMCs are found throughout the leptomeningeal coverings:

• Pia mater: Thin layer directly apposed to the brain surface
• Arachnoid mater: Middle layer with trabeculae connecting to pia
• Perivascular spaces: Surrounding penetrating arterioles and venules
• Dural border: Interface with the dura mater

Morphology

VLMCs exhibit distinctive morphological features:

• Cell body: Elongated, spindle-shaped (20-40 μm length)
• Processes: Long cytoplasmic extensions forming networks
• Junctions: Gap junctions connecting adjacent VLMCs
• Basement membrane: Produce and maintain basal lamina components

Species Differences

| Feature | Human | Mouse | Rat |
|---------|-------|-------|-----|
| Meningeal thickness | 50-300 μm | 20-50 μm | 30-80 μm |
| VLMC density | ~10^5 cells/cm² | ~5×10^4 cells/cm² | ~7×10^4 cells/cm² |
| Collagen types | I, III, IV, V | I, III, IV | I, III, IV |

Molecular Markers

VLMCs express a characteristic set of markers:

• COL1A1: Collagen type I - primary extracellular matrix component
• COL3A1: Collagen type III - co-distributes with COL1A1
• MMP2/MMP9: Matrix metalloproteinases - matrix remodeling
• PDGFRα: Platelet-derived growth factor receptor α - mesenchymal marker
• ALDH1L1: Aldehyde dehydrogenase 1L1 - metabolic marker
• CD34: Hematopoietic progenitor cell antigen - stromal marker
• PDPN (podoplanin): Lymphatic endothelial marker in dural lymphatics [3]

Function

Extracellular Matrix Production

VLMCs are the primary source of meningeal ECM:

Blood-Brain Barrier Support

VLMCs contribute to BBB maintenance through:

• Perivascular astrocyte endfoot anchoring: Via laminin deposition
• Tight junction regulation: Produce signaling molecules
• Matrix remodeling: Controlled degradation for immune cell entry
• Wnt signaling: β-catenin pathway in BBB establishment

CSF Circulation

• Arachnoid granulations: VLMCs in CSF absorption sites
• Perivascular pathways: Virchow-Robin spaces
• Meningeal lymphatic vessels: VLMCs associated with lymphatic endothelium [4]

Immune Modulation

VLMCs regulate neuroimmune interactions:

• Cytokine production: IL-6, IL-8, CCL2
• Antigen presentation: MHC class II expression
• T cell trafficking: CCR7-dependent mechanisms
• Microglial activation: Paracrine signaling

Role in Neurodegenerative Diseases

Alzheimer's Disease

VLMCs contribute to AD pathogenesis through multiple mechanisms:

Cerebral Amyloid Angiopathy (CAA)

• VLMCs produce [Aβ](/proteins/amyloid-beta) that accumulates in meningeal vessels
• Perivascular Aβ deposition disrupts vessel integrity
• Impaired perivascular drainage of interstitial fluid
• Association with hemorrhagic stroke in AD

• Reduced tight junction protein expression
• Increased paracellular permeability
• Diminished pericyte coverage
• Accelerated amyloid deposition

• Chronic low-grade inflammation in aging
• Enhanced cytokine release in AD brain
• Attraction of peripheral immune cells
• Contribution to [tau](/proteins/tau) pathology spread [5]

Parkinson's Disease

• [α-Synuclein](/proteins/alpha-synuclein) accumulation in meningeal cells
• Impaired CSF circulation
• Autonomic dysfunction via perivascular pathways
• Association with meningeal inflammation

Multiple Sclerosis

• Meningeal ectopic lymphoid follicles correlate with disease severity
• VLMC-derived cytokines perpetuate demyelination
• Fibrotic scarring in chronic lesions
• Therapeutic target for progressive MS [6]

Stroke and Traumatic Brain Injury

• Post-injury meningeal fibrosis
• Impaired CSF clearance
• Glial scar formation
• Epileptogenesis mechanisms

Therapeutic Implications

Targeting VLMC Dysfunction

Anti-fibrotic therapies

• Pirfenidone: Inhibits TGF-β signaling
• Nintedanib: Tyrosine kinase inhibitor
• Losartan: AT1 receptor blockade

• Minocycline: Microglial/VLMC modulation
• CCL2 inhibitors: Reduce immune cell recruitment
• IL-6 receptor antibodies: Tocilizumab studied

• CSF dynamics enhancers
• Perivascular drainage optimization
• Lymphatic function enhancement

Biomarker Potential

• Meningeal inflammation markers: CCL2, IL-6 in CSF
• VLMC-derived proteins: COL1A1 in plasma
• Imaging: Meningeal enhancement on MRI

Background

The study of Vascular Leptomeningeal Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed - Meninges Research](https://pubmed.ncbi.nlm.nih.gov/?term=vascular+leptomeningeal+cells)
• [Allen Brain Atlas](https://brain-map.org/)
• [BrainSpan Atlas](https://brainspan.org/)brainspan-atlas)
• [Human Protein Atlas](https://www.proteinatlas.org/)